This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
Liver Disease and Liver Transplantation
Jose Oliva, MD, AGH hepatologist and Medical Director of AGH's Liver Transplantation Program and Kusum Tom, MD, AGH Liver Transplant Surgeon
No comments:
Post a Comment